Home
/
Pharmagreen Biotech Inc.
/
Financials
/
Quarterly
Pharmagreen Biotech Inc. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that Pharmagreen Biotech Inc. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2023
Jun 30, 2023
$597
Aug 14, 2023
Q2
2023
Mar 31, 2023
$963
May 19, 2023
Q3
2023
Jun 30, 2022
$0
Aug 14, 2023
Q2
2023
Mar 31, 2022
$0
May 19, 2023
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2023
Jun 30, 2023
($162.9K)
Aug 14, 2023
Q2
2023
Mar 31, 2023
($227.4K)
May 19, 2023
Q2
2023
Dec 31, 2022
($39.4K)
May 19, 2023
Q1
2023
Dec 31, 2022
($39.4K)
Feb 14, 2023
Q3
2023
Jun 30, 2022
$251.9K
Aug 14, 2023
Q2
2023
Mar 31, 2022
($1.04M)
May 19, 2023
Q3
2022
Mar 31, 2022
($1.04M)
Aug 17, 2022
Q3
2023
Dec 31, 2021
$18.7K
Aug 14, 2023
Q2
2023
Dec 31, 2021
$18.7K
May 19, 2023
Q1
2023
Dec 31, 2021
$18.7K
Feb 14, 2023
Q3
2022
Jun 30, 2021
($142.2K)
Aug 17, 2022
Q3
2022
Mar 31, 2021
($3.14M)
Aug 17, 2022
Q2
2022
Mar 31, 2021
($3.14M)
May 16, 2022
Q1
2022
Dec 31, 2020
($417.1K)
Feb 22, 2022
Q2
2022
Dec 31, 2020
($417.1K)
May 16, 2022
Q3
2022
Dec 31, 2020
($417.1K)
Aug 17, 2022
Q3
2021
Jun 30, 2020
($1.36M)
Aug 18, 2021
Q2
2020
Mar 31, 2020
($3.5K)
May 19, 2020
Q3
2021
Mar 31, 2020
($3.6K)
Aug 18, 2021
Q3
2021
Dec 31, 2019
($206.1K)
Aug 18, 2021
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q2
2023
Mar 31, 2023
($188.0K)
May 19, 2023
Q1
2023
Dec 31, 2022
($181.1K)
Feb 14, 2023
Q3
2022
Jun 30, 2022
($241.2K)
Aug 17, 2022
Q2
2023
Mar 31, 2022
($1.04M)
May 19, 2023
Q1
2023
Dec 31, 2021
($203.7K)
Feb 14, 2023
Q3
2022
Jun 30, 2021
($232.4K)
Aug 17, 2022
Q2
2022
Mar 31, 2021
($136.9K)
May 16, 2022
Q1
2022
Dec 31, 2020
($101.6K)
Feb 22, 2022
Q3
2021
Jun 30, 2020
($86.9K)
Aug 18, 2021
Q2
2021
Mar 31, 2020
($150.6K)
May 24, 2021
Q1
2020
Dec 31, 2019
($117.1K)
Feb 18, 2020
Q3
2020
Jun 30, 2019
($58.3K)
Aug 19, 2020
Q2
2020
Mar 31, 2019
($93.6K)
May 19, 2020
Q1
2020
Dec 31, 2018
($205.3K)
Feb 18, 2020
Q3
2019
Jun 30, 2018
($328.4K)
Aug 19, 2019